Everolimus for the treatment of subependymal giant cell astrocytoma probably causing seizure aggravation in a child with tuberous sclerosis complex: A case report

Neuropediatrics

Volumn 45, Issue 2, 2014, Pages 129-131

  Wiemer Kruel, Adelheid ^a   Woerle, H ^b   Strobl, K ^a   Bast, T ^a  

^a Epilepsy Center Kork   (Germany)

^b KLINIKUM STUTTGART   (Germany)

Author keywords

everolimus; seizure aggravation; subependymal giant cell astrocytoma; tuberous sclerosis complex

Indexed keywords

BROMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; EVEROLIMUS; LAMOTRIGINE; LORAZEPAM; MESUXIMIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; SULTIAME; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; ANTINEOPLASTIC AGENT; RAPAMYCIN;

ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; BLISTER; CASE REPORT; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; HUMAN; KETOGENIC DIET; LOADING DRUG DOSE; MUCOSA INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY OF LIFE; SEIZURE; SLEEP DISORDER; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; TONIC CLONIC SEIZURE; TONIC SEIZURE; TUBEROUS SCLEROSIS; ANALOGS AND DERIVATIVES; ASTROCYTOMA; CHEMICALLY INDUCED; COMPLICATION; STATUS EPILEPTICUS;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ASTROCYTOMA; EPILEPSIES, PARTIAL; FEMALE; HUMANS; SEIZURES; SIROLIMUS; STATUS EPILEPTICUS; TUBEROUS SCLEROSIS;

EID: 84897108682     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0033-1360481     Document Type: Article

References (6)

1. Franz D. N., Leonard J., Tudor C., et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol: 2006; 59 3 490 498 (Pubitemid 43358069)
2. Bebin M., Franz D. N., Sahmoud T., et al. Everolimus in Subependymal Giant Cell Astrocytomas (SEGA) Associated with Tuberous Sclerosis Complex (TSC): Results of EXIST-1, a Double-Blind Placebo-controlled Phase III Trial. Eur J Cancer: 2011; 47 02 4 16
3. Krueger D. A., Care M. M., Holland K., et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med: 2010; 363 19 1801 1811
4. Franz D. N., Belousova E., Sparagana S., et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet: 2013; 381 (Issue 9861): 125 132
5. Krueger D. A., Wilfong A. A., Holland-Bouley K., et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. (e-pub ahead of print) 2013; doi: 10.1002/ana.23960
6. Kotulska K., Chmielewski D., Borkowska J., et al. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. EJPN: 2013; 17 5 479 485